Butamyrate citrate, 2-(2-diethylaminoethoxy)ethyl 2-phenylbutamyrate dihydrogen citrate, is widely used as a central cough suppressant.
Derivative spectrophotometric procedures and an isocratic high performance liquid chromatographic method for the determination of butamyrate citrate (Sinecod ® , Safarol ® ) in cough syrups have been developed. In the spectrophotometric method, direct measurement of the drug at its absorption maxima is impossible because of interference from different absorbing excipients. Extraction of butamyrate citrate was performed with n-pentane/isopropyl alcohol. Quantification was carried out through the use of 1 D derivative at a trough depth of 253.6 nm where interferences from other coextracted compounds are negligible. The extraction efficiency expressed as a % recovery and precision were assessed by fortifying placebo syrup(s) with known amounts of the compound. Also, a reversed phase high performance liquid chromatographic method was used with a mobile phase containing 0.015 M aqueous tetraethylammonium hydrogen sulfate, methanol and acetonitrile 40:30:30 adjusted to pH 3.50 with ammonium hydroxide. The retention behavior of butamyrate citrate as a function of both pH and salt concentration in the aqueous portion of the mobile phase was investigated. Quantification was achieved with UV detection at 258 nm based on peak area. The HPLC method clearly separates the analyte from its degradation products derived after storage of samples under different stress conditions such as acid, alkaline, temperature, oxygen and light. The described methods were successfully applied to the determination of butamyrate citrate in commercial pharmaceutical products and in placebo syrups prepared in the laboratory with good accuracy and precision. The results of the present study show that the use of the derivatives and the HPLC procedure provide precise and sensitive methods for the determination of the compound in pharmaceutical formulations. transferred to 10 mL volumetric flasks, and the volume was made up to 10 mL or 25 mL with 0.5 N HCl, 0.5 M NaOH and 3% hydrogen peroxide correspondingly. The mixtures were left at room temperature for 36 h or incubated at 65˚C for about 45 min. Then they were cooled at room temperature, filtered through a 0.45 µm syringe filter and injected onto the column to detect peaks of degradation. Similarly, to check for degradation products, dilutions from stock solution were made using HPLC grade water and mobile phase (in separate volumetric flasks). Then each sample was heated at 65˚C for 45 min or exposed to direct lamp light (or sunlight) for 36 h.
Instrumentation
The HPLC apparatus consisted of a Shimadzu Series LC-6A and an SPD-6AV UV spectrophotometric detector, controlled by an SCL-6B system programmer module and operated at 258 nm. Chromatograms were recorded on chart paper using a Shimadzu Chromatopac Model GR-6A thermal printer-plotter at a speed of 2 mm/min. An Alltech (Lichrosorb RP-18, 5 µm, 250 mm × 4.6 mm i.d.) reversed phase column was placed in a Model CTO-6A oven set at 40˚C and equipped with a Rheodyne injector Model 7167 with a 20 µL loop. The mobile phase was composed of 0.015 M tetraethylammonium hydrogen sulfate buffer-methanol-acetonitrile, 40:30:30, and was delivered to the column isocratically at a flow rate of 0.6 mL/min.
The same chromatographic analysis was also carried out on a Spectra System, TSP (Thermo Separation Products, Austin, TX, USA), a P4000 tertiary solvent pump, an AS3000 autosampler equipped with a 20 µL loop and a UV6000LP diode array detector. The mobile phase flow-rate was set at 0.6 mL/min and degassing was carried out on-line by use of TSP degasser. Injections of 20 µL were made by use of a TSP liquid autosampler. Detection and identification of the compound were based on UV spectra scanned in 240 -380 nm range (long wavelength benzenoid B band) at 1 nm sampling intervals. The chromatographic data were monitored and processed by a ChromQuest (TSP) program.
A Shimadzu UV-Vis double beam spectrophotometer Model UV-2501 PC consisted of a double monochromator with a high performance double-blazed holographic grating in the aberration corrected Czerny-Turner mounting and a light source of both a 50 W halogen lamp and a D2 lamp. The optimized operating conditions for spectrophotometric measurements were derivative modes 2 D (d 2 A/dλ 2 ), and 1 D (d 1 A/dλ 1 ) scan speed fast, slit width 1.0 nm and sampling interval 0.1 nm. Derivative UV spectra were recorded over a wavelength range of 200 -300 nm using 1.0 cm matched quartz cells. The system was interfaced with a computer and spectra were recorded on paper and simultaneously digitalized and stored on diskettes.
Results and Discussion

Derivative procedure
Butamyrate citrate cannot be directly determined by zeroorder UV-spectrophotometry because the spectrum in syrup samples is completely covered by the presence of different excipients. This is clearly illustrated in Fig. 1A , where a concentration of 496 µg mL -1 of butamyrate citrate in methanol exhibits the secondary benzenoid band B with its fine structure, whereas an aliquot from a commercial syrup sample (Sinecod ® , labeled amount 1.5 mg/mL), after dilution by a factor of 25, yields a completely overlapped spectrum. After extraction procedure, the nonspecific UV absorption continues to exhibit an extreme blurring in the secondary benzenoid band B of the compound.
Therefore the zero order spectrophotometric method encounters the severe problem of the syrup background, which makes butamyrate citrate determination impossible in this matrix.
On the other hand, though derivative transformation does not increase the information content of the butamyrate spectrum, it does permit discrimination against broad band interference arising from any nonspecific matrix absorption. It also enhances subtle spectral features of the data by presenting them in a new and visually more accessible way. In other cases the method circumvents the problem of light scattering caused by light turbidity in the extracted samples. Figure 1B presents a series of solutions derived from placebo syrup after a neutralization extraction procedure of butamyrate citrate, ranging from 135.9 to 453.0 µg/mL. The distortion of the spectrum in the presence of different excipients which are coextracted together with the drug is noticeable. The 1 D first and 2 D second derivative spectra of the same series of samples are shown in Fig. 2 , where elimination of background absorption together with the distortion of spectra are clearly presented.
In the present work the measurements selected are those which exhibit the highest signal(s), give the best linear response and are least affected by the presence of any other components. In order to find the most appropriate derivative order and the wavelength of measurements, series of standard solutions and syrup samples of different concentrations were prepared in the laboratory; after extraction they were submitted to first and second derivative processing. Table 1 and Fig. 3 show the regression line characteristics and correlation parameters for the determination of butamyrate citrate by 1 D253.6 first derivative and HPLC methods. Evaluation of the spectra shows that the depth of trough at the 1 D253.6 derivative value 253.6 nm in methanol solution exhibits not only a high response but also negligible interference. This therefore appeared to be an optimum reference point for butamyrate citrate determination.
Regression analysis of the data obtained by running a series of working solutions of 99.2, 148.8, 198.4, 248.0, 297.6, 347.2, 396.2, 446.4 and 496.0 µg/mL at 1 D253.6 shows the calibration response of the analyte to be linear in the employed range studied. The calibration graph that is based on nine data points can be described by the equation: y = 2.75 × 10 -5 x + 1.36 × 10 -4 , r = 0.9985, where y represents the amplitude of depth at 253.6 nm.
In fact, the linearity of the calibration graph, the adherence of the system to Beer's law, and the negligible scatter of the experimental points together with that of the residuals were validated by the values of the correlation coefficient and the values of intercept which were close to zero. 5 The intercept value was not statistically different from zero. The concentration in each commercial sample or spiked placebo was determined from the calibration graph by intrapolation.
Extraction procedure
The extraction efficiency expressed as a % recovery and the extraction precision were assessed by fortifying placebo syrup with known amounts of butamyrate citrate. The placebo syrup prepared in the laboratory consisted mainly of glycerol sol. 85% USP, sorbitol sol. 70% USP, propylene glycol and saccharine sodium. Also, a reference stock solution of butamyrate citrate was prepared using methanol as the solvent. Aliquots from this were transferred into a series of different tubes and evaporated 565 ANALYTICAL SCIENCES APRIL 2003, VOL. 19 Fig. 2 (A) First and (B) second derivative spectra of a series of solutions, ranging from 135.9 to 453.0 µg/mL in methanol, derived from placebo syrup after neutralization extraction procedure. to dryness under a stream of nitrogen at ambient temperature. To these residues, 3.0 mL of the prepared placebo syrup was added; each sample was vortexed, placed in a hot water bath and ultrasonicated for 10 -12 min. Then a few drops of 4 M NaOH solution were added to the fortified syrup and mixed briefly to make it alkaline. Different extraction media like chloroform, ether, ethylacetate and n-pentane in combination with isopropyl or isoamyl alcohol were initially employed for liquid-liquid extraction and sample clean up. N-Pentane containing isopropyl alcohol was chosen as the most appropriate solvent because of its low evaporation time, very clean extracts, and the relatively high extraction yield of the compound. Incremental changes in n-pentane composition from 96:4 v/v (npentane:isopropyl alcohol) through to 100% pentane gave an optimal ratio of 98:2 v/v.
Three × 3-mL quantities of the organic extractants were added to the fortified samples. Then the mixture(s) were vortex-mixed at a high speed for 2 min and centrifuged at 2000 rpm for 5 min in order to separate the two phases clearly. The upper organic layers were transferred into another adapted tube with a small nipple-like protrusion at the base and evaporated to dryness under a stream of nitrogen at ambient temperature for almost 10 min. The residue was re-dissolved by the addition of 4 mL methanol and 1.0 cm matched quartz cells were used for measurements. The extraction efficiency and precision of the whole procedure were assessed by spiking blank syrup samples with butamyrate citrate at five fortification levels and analyzing five replicates. The amounts found in this spiked sample were computed from the regression analysis. Table 2 presents the spiked level recovery and precision data.
Chromatographic conditions for optimum separation
Different mobile phases and reversed columns were employed for the separation and quantification of butamyrate citrate in different cough preparations. A mobile phase containing water-methanol-acetonitrile was found to produce promising chromatographic behavior of the chromatographic peak. The presence of ammonium acetate buffer in the mobile phase generally yields peaks with acceptable symmetry but in our case the use of the above buffer gave badly tailing peaks. No elution occurred when the above buffer was used in combination with methanol or acetonitrile alone. Facing such difficulties it was thought efficient to add two salts separately in the aqueous portion of the mobile phase. In fact tetrabutylammonium hydrogen sulfate and tetraethylammonium hydrogen sulfate proved sufficient to improve chromatographic behavior of the compound and to separate it from various excipients encountered in syrup preparations. Employing the above buffer(s) separately, we investigated the chromatographic behavior of butamyrate in order to assess the relationship between the capacity factor k′ and the mobile phase properties, such as the pH of the aqueous portion of the mobile phase and the salt content. It was observed that basic drugs are generally eluted with difficulty in their un-ionized form. In this particular study at low pH, the proportion of protonated species was increased and, as a consequence, the magnitude of the ionic interaction between the solute and the mobile phase increased. Low pH values were seen to considerably affect the chromatographic behavior of the drug. Figure 4 shows the predicted retention behavior of the butamyrate as a function of both pH and salt content in the mobile phase. The effect of salt content was studied at different concentrations of tetraethylammonium hydrogen sulfate in the mobile phase and in combination with a pH range. A response surface method based on a non linear multiple regression analysis was used to illustrate the k′ values for certain compositions of pH values and different concentrations of salt content in the mobile phase, with the total number of numerical k′ values being 25 (r = 0.9982). The method was applied by using the Sigmaplot ® 4.0, a technical graphing computer program covering unordered triplet data in mesh format. On the basis of the chromatographic behavior of the active compound, optimum conditions with good peak symmetry, reasonable retention time (8.26 min), and a distinct separation among butamyrate and other excipients was achieved. In fact ionization of the drug substance enhanced the elution ability of mobile phases at low pH values and improved the separation mode. The retention time of butamyrate was found to be reproducible under the described condition: aqueous 0.015 M tetraethylammonium hydrogen sulfate-CH3OH-CH3CN, 40:30:30, adjusted to pH 3.50 with ammonium hydroxide.
Specificity of the method using degradation products
The specificity or selectivity of an analytical method is its ability to measure the analyte accurately and specifically in the presence of other components which may be expected to be present in the sample matrices. It allows the measurement of the degree of interference, or absence thereof, in the analysis of complex sample mixtures. Sometimes it is not possible to be completely confident that the developed system has chromatographically resolved all the compounds in a sample and it might be suspected in such cases that a particular chromatographic peak might be due to more than one component. 6, 7 In our case some stress conditions, such as oxidation, degradation by acid and base, temperature and light were employed to test the selectivity of the method. Figure 5 shows butamyrate citrate and its degradation products derived under alkaline condition.
In addition, the purity of the chromatographic peak of the compound was checked using a diode array detector. In all cases "peak purity" values derived automatically from the ChromQuest (TSP) program, were in the range 0.991 -0.998. Moreover the spectrum from the leading edge of the peak and that of the apex were normalized to get the best possible overlay. The absorbances across the spectral bands were overlaid manually against each other. Data pairs of absorbance were plotted on a scatter diagram, the "spectrum of the apex" (assumed to be more precise) on the abscissa and the spectrum of the leading edge on the ordinate. Linear regression analysis of data gave the following equation: y = 0.910x + 0.208, r 2 = 0.9962. Figure 6 shows the overlaid normalized spectra and the correlation diagram. It was observed that butamyrate citrate was more susceptible to degradation in alkaline and oxidative conditions.
Applications
Representative HPLC chromatograms are shown in Fig. 5 . Butamyrate exhibits an individual symmetrical peak, whereas different excipients and preservatives are eluted with the solvent front. Moreover, Table 1 and Fig. 3 illustrate regression analysis and correlation data of the calibration curve, indicating a linear relationship between peak area and concentration. The commercially available syrups Sinecod ® (1.5 mg/mL) and Safarol ® (5 mg/mL) and the spiked syrup(s) were analyzed employing the 1 D253.6 first derivative spectrophotometric procedure and the HPLC method. The results were within acceptable limits according to the labeled or added amount.
Conclusion
The applicability of the methods for the assay of butamyrate citrate in commercial cough syrups and in laboratory-prepared syrup samples was successfully analyzed by the proposed methods. The procedures already described meet most demands of pharmaceutical analyses: simplicity, sensitivity, rapidity, selectivity and cost of analysis. The HPLC procedure allows the determination of drug levels in pharmaceutical matrices without sample pretreatment. Thus interference from other components and additives is avoided.
Moreover, the chromatographic system developed clearly separates the analyte from its degradation products and this makes the presented procedure especially valuable. On the other hand, the firstderivative spectrophotometric method provides an easy procedure where minimum sample preparation is required. The methods might be considered suitable for the assay and evaluation of both pharmaceutical preparations and butamyrate citrate in bulk substances. 
